Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/1996
02/28/1996EP0547126B1 Biodegradable polymers containing diester units
02/28/1996EP0494978B1 Heterocyclic compounds
02/28/1996EP0469010B1 Cosmetic composition
02/28/1996CN1117743A Method to predict active growth of bacteria adhered to a surface
02/28/1996CN1117735A Steroids for treating menopausal complaints
02/28/1996CN1117734A 3'-aziridino-anthracycline derivatives
02/28/1996CN1117733A Silylated acetylcholinesterase inhibitors
02/28/1996CN1117731A Heteroaromatic compounds with antipsychotic activity
02/28/1996CN1117727A Indolin-2-one derivative
02/28/1996CN1117711A potentiation of temozolomide in human tumour cells
02/28/1996CN1117705A Compositions and uses thereof
02/28/1996CN1117498A Prepn. method and application of sodium hyaluronate
02/28/1996CN1117493A Azaaliphatatially bridged quinoxaline-2,3-diones
02/28/1996CN1117492A Treatment of H. pylori infections
02/28/1996CN1117491A 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
02/28/1996CN1117487A Process for preparing carboxamides
02/28/1996CN1117484A Fatty acid derivatives
02/28/1996CN1117383A Cefixime composition
02/28/1996CN1117382A Defervescent for children
02/28/1996CN1117381A Medicinal prepn. for treating ringworm
02/28/1996CN1117380A Aerosol for treating heart disease
02/28/1996CN1031132C Process for preparation of carbocyclic adenosine analogs useful as immunosuppressants
02/27/1996WO1996006602A1 COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
02/27/1996US5495048 Anticholesterol agents
02/27/1996US5495046 Psychological disorders
02/27/1996US5495044 Inhibitors of kynureninase
02/27/1996US5495043 Substituted di-t-butylphenols
02/27/1996US5495032 Process for producing 7-(substituted)-8-(substituted-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
02/27/1996US5495031 Process for the production of 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
02/27/1996US5495030 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines
02/27/1996US5495023 Nitro compounds, process for preparation thereof and use thereof
02/27/1996US5495022 Antiarrhythmic, isotropic agents
02/27/1996US5495021 Benzo[f]quinolinones
02/27/1996US5495020 Chemical intermediate for bactericides, microbiocides, disinfectants; side effect reduction, absorption
02/27/1996US5495018 7-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
02/27/1996US5495013 Process for the preparation of Diltiazem
02/27/1996US5495010 Acid stable purine dideoxynucleosides
02/27/1996US5494994 Salts of pyromellitic acid, a process for their preparation and their use
02/27/1996US5494936 Delivery formulation for probucol
02/27/1996US5494935 Chelation of heavy metals from humans and animals using polyaminocarboxylic acids
02/27/1996US5494934 Antidepressants, hypotensive agents
02/27/1996US5494933 Treatment
02/27/1996US5494932 Aids, retroviruses, herpes viruses, cytomegalovirus
02/27/1996US5494931 Anticoccidial in poultry, preventing and treating swine dysentery, growth promoter in cattle and swine
02/27/1996US5494929 Administering to humans
02/27/1996US5494928 Indole derivatives
02/27/1996US5494927 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
02/27/1996US5494925 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
02/27/1996US5494924 Therapeutical method for the treatment of dermatoses using O-esters of L-carnitine
02/27/1996US5494923 Method of ameliorating cerebral circulation
02/27/1996US5494922 Anticoagulants
02/27/1996US5494921 Fibrinogen receptor antagonists
02/27/1996US5494920 Using a benzothiophene compound
02/27/1996US5494918 Anticholesterol agents
02/27/1996US5494917 Cognition enhancing quinuclidine compound
02/27/1996US5494916 Imidazo[4,5-C]pyridin-4-amines
02/27/1996US5494915 Isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same
02/27/1996US5494914 Useful for treatment of diseases whose progress is aided by activation of androgen receptors
02/27/1996US5494912 9-purinyl phosphonic acid derivitives for treating gout
02/27/1996US5494911 Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
02/27/1996US5494910 Benzofuran derivatives as 5-HT1 -like receptor antagonists
02/27/1996US5494909 Antiischemic agents
02/27/1996US5494907 11-β substituted-19-nor steroids
02/27/1996US5494906 Treating metabolic bone disease
02/27/1996US5494905 Vitamin D amide derivatives
02/27/1996US5494901 Includes carbonic anhydrase inhibitor
02/27/1996US5494900 UDPG as a rescue agent in cancer therapy after the administration of antipyrimidine or related anti-tumor agents with or without BAU
02/27/1996US5494899 Immunomodulation of bone marrow cells in culture using hormones during pregnancy, such as estrogen; autoimmune disorders, osteoporosis
02/27/1996US5494820 Streptomyces braegensis strain and its cultivation in a process for producing C9 -desoxo-FK-520
02/27/1996US5494682 Encapsulated biomass in crosslinked polymer material
02/27/1996US5494680 Transdermal delivery device
02/27/1996US5494676 Dermatological compositions containing CIS-urocaninic acid
02/27/1996US5494672 Pseudomonas peptide composition and method
02/27/1996US5494670 Method of treating ketosis
02/27/1996US5494666 Beta-lactamase inhibitors, antibacterials
02/27/1996US5494664 Bifidobacteria
02/27/1996US5494661 Froom a croton species, administering in vivo to humans or animals
02/27/1996US5494660 Treating surfaces with biologically active block polymer of ethylene glycol, propylene glycol, and ethylenediamine
02/27/1996CA2170505A1 Compositions and methods for the administration of .delta.-aminolevulinic acid and pharmaceutical equivalents thereof
02/27/1996CA2155447A1 Substituted biphenyl isoxazole sulfonamides
02/27/1996CA2030204C Pharmaceutical compositions of tebufelone
02/27/1996CA2015738C Vitamin and mineral supplements
02/27/1996CA2009118C Method and composition for cleaning and disinfecting contact lenses
02/27/1996CA1338089C Sulfonic acid esters
02/27/1996CA1338085C Antibiotics bu-3608d and bu-3608e from actinomadura
02/27/1996CA1338083C Ozonides of terpenes and their medical uses
02/26/1996CA2156788A1 Use of 6-amino-1,4-dihydropyridines as medicaments for treatment of the central nervous system, and processes for their preparation
02/26/1996CA2156674A1 Cyclohexadiene derivatives
02/26/1996CA2156673A1 Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments
02/26/1996CA2156672A1 2,3-bridged 1,4-dihydropyridines, processes for their preparation and their use as medicaments
02/25/1996CA2156700A1 Pharmaceutical compounds
02/25/1996CA2155986A1 .alpha.-phosphonosulfinate squalene synthetase inhibitors and method
02/24/1996CA2156768A1 Pharmaceutical formulations, their preparation and use
02/24/1996CA2141761A1 Ionone disinfectant
02/23/1996CA2154807A1 Method of treating or preventing cardiac arrhythmia employing an n-substituted heterocyclic derivative
02/22/1996WO1996005544A1 Current-to-pressure transducer with selectable, adjustable input filter
02/22/1996WO1996005321A1 Gene therapy for restenosis using an adenoviral vector
02/22/1996WO1996005320A1 Adenovirus comprising a gene coding for glutathion peroxidase
02/22/1996WO1996005298A1 Antitumor antisense oligonucleotides
02/22/1996WO1996005289A1 Enhanced activation of natural killer cells using an nk cell activator and a hydrogen peroxide scavenger or inhibitor
1 ... 6940 6941 6942 6943 6944 6945 6946 6947 6948 6949 6950 6951 6952 6953 6954 6955 6956 6957 6958 6959 6960 ... 7860